Spanish Red Biotech Pipeline

FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria)

Treatment of epidermolysis bullosa

Type: Gene / Cell Therapy
Therapeutic area:
Indication: Genome editing in primary keratinocytes for Epidermolysis bullosa treatment
Phase: 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical